Triplex International Biosciences (China) Co., Ltd, products

The Dengue NS1 Antigen Rapid Test Kit is designed primarily for rapid in vitro qualitative assessment of the Dengue NS1 antigen present in human serum, plasma, and whole blood samples collected via venipuncture or fingerstick. This product is strictly intended for professional in vitro diagnostic use, assisting healthcare professionals in the detection of Dengue virus. The kit comes equipped with a test card and accompanying sample diluent, along with a dropper and manual instruction guide. Variants available include packages of different test quantities (1, 5, 10, and 25 tests per kit), each offering corresponding sample diluent volumes (100μL to 2.5mL) to suit various testing requirements. Ensuring a user-friendly experience, the kit aims to aid efficient and timely diagnosis of the Dengue infection through qualitative testing.

The p16 protein/Ki-67 Dual Staining Kit offered by Triplex International Biosciences is designed to aid in the evaluation of cellular proliferation and potential disruptions in the cell cycle. The kit employs two key biomarkers: the p16 protein, a cyclin-dependent kinase inhibitor that plays a critical role in the regulation of the cell cycle, and Ki-67, a known marker for cell proliferation which is expressed primarily during the mitotic phase. The overexpression of p16 can occur due to the disruption of cellular processes driven by the integration of HPV and host genes, which leads to uncontrolled proliferation. Simultaneous detection of both p16 and Ki-67 in cervical epithelial cells serves as a crucial indicator of abnormal cellular proliferation and potential lesions. This ready-to-use kit features vibrant color indicators, a long shelf life, and convenient storage conditions. Additionally, it includes necessary cytological consumables for ease of use in laboratory settings.

The SARS-CoV-2 & Flu A+B Antigen Combo Rapid Test Kit, provided by Triplex International Biosciences, is a diagnostic tool designed for quick identification of SARS-CoV-2, influenza A, and influenza B viruses. This kit utilizes an in vitro approach to qualitatively detect nucleoprotein antigens from nasopharyngeal, nasal, oropharyngeal swabs, or saliva samples within 15 to 20 minutes. It is engineered for ease of use with simple procedures such as buffer solution mixing and sample application. The kit is particularly advantageous for its versatility in sample types and its practical transportation and storage requirements at room temperature. This product serves healthcare professionals in efficiently diagnosing viral infections, crucial for managing and curbing the spread of these contagious diseases, making it a valuable asset in clinical and field settings.